Citigroup Inc. Buys 96,180 Shares of The Cooper Companies, Inc. $COO

Citigroup Inc. raised its stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 84.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 210,699 shares of the medical device company's stock after purchasing an additional 96,180 shares during the quarter. Citigroup Inc. owned 0.11% of Cooper Companies worth $17,772,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently modified their holdings of COO. Covestor Ltd grew its stake in shares of Cooper Companies by 35.5% in the 4th quarter. Covestor Ltd now owns 458 shares of the medical device company's stock valued at $42,000 after purchasing an additional 120 shares during the last quarter. Sagespring Wealth Partners LLC acquired a new position in Cooper Companies during the fourth quarter worth $244,000. Mariner LLC increased its position in Cooper Companies by 10.4% during the fourth quarter. Mariner LLC now owns 34,142 shares of the medical device company's stock worth $3,139,000 after buying an additional 3,220 shares in the last quarter. XTX Topco Ltd purchased a new position in Cooper Companies during the fourth quarter worth $824,000. Finally, Canada Post Corp Registered Pension Plan purchased a new position in Cooper Companies during the fourth quarter worth $331,000. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Cooper Companies Trading Up 0.4%

COO stock traded up $0.27 during mid-day trading on Monday, reaching $73.53. 369,089 shares of the stock traded hands, compared to its average volume of 2,147,133. The stock's fifty day moving average is $71.92 and its 200-day moving average is $78.84. The company has a market cap of $14.71 billion, a P/E ratio of 35.70, a P/E/G ratio of 1.79 and a beta of 1.00. The Cooper Companies, Inc. has a 52-week low of $65.00 and a 52-week high of $112.38. The company has a current ratio of 2.10, a quick ratio of 1.23 and a debt-to-equity ratio of 0.30.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its quarterly earnings data on Thursday, May 29th. The medical device company reported $0.96 EPS for the quarter, topping analysts' consensus estimates of $0.93 by $0.03. Cooper Companies had a return on equity of 9.60% and a net margin of 10.39%. The firm had revenue of $1 billion for the quarter, compared to the consensus estimate of $995.12 million. During the same quarter in the prior year, the company posted $0.85 earnings per share. The firm's revenue was up 6.3% on a year-over-year basis. As a group, sell-side analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Analyst Ratings Changes

A number of research firms have issued reports on COO. Loop Capital set a $100.00 price target on Cooper Companies in a research report on Tuesday, June 17th. JPMorgan Chase & Co. reiterated a "neutral" rating and issued a $76.00 price target (down previously from $110.00) on shares of Cooper Companies in a research note on Friday, May 30th. Wells Fargo & Company cut their price objective on Cooper Companies from $118.00 to $93.00 and set an "overweight" rating on the stock in a research note on Friday, May 30th. Wall Street Zen lowered shares of Cooper Companies from a "buy" rating to a "hold" rating in a research note on Saturday, July 12th. Finally, UBS Group raised Cooper Companies to a "buy" rating in a report on Tuesday, June 17th. Three analysts have rated the stock with a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $96.73.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.